Literature DB >> 7148879

Serum estrogen levels in men with acute myocardial infarction.

E L Klaiber, D M Broverman, C I Haffajee, J S Hochman, G M Sacks, J E Dalen.   

Abstract

Serum estradiol and serum estrone levels were assessed in 29 men in 14 men in whom myocardial infarction was ruled out; in 12 men without apparent coronary heart disease but hospitalized in an intensive care unit; and in 28 men who were not hospitalized and who acted as control subjects. (The 12 men who were hospitalized but who did not have coronary heart disease were included to control for physical and emotional stress of a severe medical illness.) Ages ranged from 21 to 56 years. Age, height, and weight did not differ significantly among groups. Blood samples were obtained in the patient groups on each of the first three days of hospitalization. The serum estrone level was significantly elevated in all four patient groups when compared with that in the control group. Estrone level, then, did not differentiate patients with and without coronary heart disease. Serum estradiol levels were significantly elevated in the groups with myocardial infarction, unstable angina, and in the group in whom myocardial infarction was ruled out. However, estradiol levels were not significantly elevated in the group in the intensive care unit without coronary heart disease when compared to the level in the normal control group. Serum estradiol levels, then, were elevated in men with confirmed or suspected coronary heart disease but were not elevated in men without coronary heart disease even under the stressful conditions found in an intensive care unit. Serum estradiol levels were significantly and positively correlated (p less than 0.03) with serum total creatine phosphokinase levels in the patients with myocardial infarction. The five patients with myocardial infarction who died within 10 days of admission had markedly elevated serum estradiol levels. The potential significance of these serum estradiol elevations is discussed in terms of estradiol's ability to enhance adrenergic neural activity and the resultant increase in myocardial oxygen demand.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7148879     DOI: 10.1016/0002-9343(82)90779-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

1.  Gender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery.

Authors:  Stefan Scheingraber; Daniel Dobbert; Peter Schmiedel; Ewald Seliger; Henning Dralle
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  The protective mechanism of estrogen on high blood pressure.

Authors:  A W von Eiff; H M Lutz; J Gries; R Kretzschmar
Journal:  Basic Res Cardiol       Date:  1985 Mar-Apr       Impact factor: 17.165

3.  The effect of ketoconazole and transdermal estradiol on serum sex steroid hormones levels.

Authors:  G S Hughes; S F Francom; C R Spillers; T V Ringer
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  The low plasma testosterone levels of young Indian infarct survivors are not due to a primary testicular defect.

Authors:  M Sewdarsen; I Jialal; R K Naidu
Journal:  Postgrad Med J       Date:  1988-04       Impact factor: 2.401

5.  Serum estradiol concentration as a predictor of death in critically ill and injured adults.

Authors:  Lesly A Dossett; Brian R Swenson; Heather L Evans; Hugo Bonatti; Robert G Sawyer; Addison K May
Journal:  Surg Infect (Larchmt)       Date:  2008-02       Impact factor: 2.150

6.  High levels of endogenous estrogens are associated with death in the critically injured adult.

Authors:  Lesly A Dossett; Brian R Swenson; Daithi Heffernan; Hugo Bonatti; Rosemarie Metzger; Robert G Sawyer; Addison K May
Journal:  J Trauma       Date:  2008-03

7.  Sex hormone concentrations in men with angiographically assessed coronary artery disease--relationship to obesity and body fat distribution.

Authors:  H Hauner; K Stangl; K Burger; U Busch; H Blömer; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1991-09-16

8.  CYP17A1 deficient XY mice display susceptibility to atherosclerosis, altered lipidomic profile and atypical sex development.

Authors:  Jeanette Erdmann; Zouhair Aherrahrou; Redouane Aherrahrou; Alexandra E Kulle; Natalia Alenina; Ralf Werner; Simeon Vens-Cappell; Michael Bader; Heribert Schunkert
Journal:  Sci Rep       Date:  2020-05-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.